NASDAQ RESUMED AT 11:00 AM
NASDAQ RESUMEDAT 11:00 AM
Recent news on Tcgx Acquisition
See all newsBrief: Trigemx Bio And Tcgx Acquisition Corp. Announce Business Combination Agreement To Create Publicly Listed Company To Develop Elismetrep, A Potential First-In-Class Treatment For Migraine
Brief: TCGX Acquisition Corp. Ii Announces Pricing Of $100,000,000 Initial Public Offering
Brief: Tcgx Acquisition Corp II Files $100 Million IPO For 10 Million Class A Shares
NASDAQ RESUMED AT 11:00 AM
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:00 AM